Nu Skin announced its financial results for the first quarter of 2026. Revenue was $320.6 million, a 12% year-over-year decrease, but well within the company’s previously released financial guidance range. Gross margin was 66.9%. Customer and paid affiliate numbers fell 14% and 8% respectively, to 669,535 and 120,850. Sales leader numbers fell 13% year-over-year to 26,915.
“We delivered first quarter revenue in line with our expectations and made further progress in our strategic priorities while operating in a volatile environment,” said Ryan Napierski, Nu Skin President and CEO. “As we move through 2026, we are focused on empowering our sales leaders to scale our intelligent wellness platform with our latest innovation, Prysm iO, ahead of our full consumer rollout in the second half. We also continue to invest in laying the groundwork to expand our presence in emerging markets, including the formal launch of India anticipated in late 2026, while continuing to improve our operational discipline to return value to shareholders. We are encouraged by early signs of improving paid affiliates and new sales leader development in several markets as our leaders begin integrating Prysm iO into their businesses and continue to build upon our leading anti-aging Tru Face brand. We are focused on partnering with our sales force on leveraging the proprietary nutritional health biomarker tracking from Prysm iO to expand the channel as we prepare to drive customer subscriptions for our wellness products. While these initiatives will take time to develop, we remain confident that they will increase sales leader engagement and expand our global reach over time to drive the next phase of growth for Nu Skin.”
Second quarter 2026 guidance now includes revenue between $330 million to $360 million with an EPS between $0.15 to $0.25. Full year 2026 guidance now includes revenue between $1.35 billion to $1.5 billion with an EPS between $0.70 to $1.10.
“In addition to delivering on revenue and adjusted earnings, we returned $8 million to shareholders in the form of dividends and share repurchases,” said Chelsea Lantz, Nu Skin Interim Chief Financial Officer. “We were also able to refinance our debt, extending our liquidity as we invest in growth initiatives and navigate market volatility while executing on our strategy. We are maintaining our annual guidance for 2026 on an adjusted basis. For the second quarter, we project revenue between $330 million and $360 million, with earnings per share in the range of $0.15 to $0.25.”
